1Abecasis R, Guevara M, Miguez C, et al. Long-term efficacy of torasemide compared with furosemide in hepatic cirrhotic patients with ascites. Scand J Gastroenterol, 2001,36:309-313.?A
2Fortuno A, Muniz P, Ravassa S, et al. Torasemide inhibits angiotensin Ⅱ-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension, 1999,34:138.
3Cosin J, Diez J, TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail,2002,4: 507-513.
4Muller K, Gamba G, Jaquet F, et al. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA Ⅱ to Ⅳ--efficacy and quality of life. Eur J Heart Fail, 2003,5:793-801.
5Vasavada N, Saha C, Agarwal R. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.Kidney Int, 2003,64: 632-640.
7Hunt Baker DW,Chin MH,et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 2001, 11,2996-3007.
8Frieder HA, Buckley MM-T. Torasemide-a review of its pharmacology,properties and therapeutic potential. Drugs, 1991,41:81-103.
9Brater DC. Clinical pharmacology of loop diuretics. Drugs, 1991,41:14-22.
10Stauch M, Stiehl L. Controlled, double-blind clinical trial on the efficacy and tolerance of torasemide in comparison with furosemide in patients with congestive heart failure-a multicenter study. In:Kruck F, Mutschler E, Knauf H, eds. Torasemide: clinica
